Lexicon Gross Profit Trend from 2010 to 2022

LXRX
 Stock
  

USD 2.14  0.12  5.31%   

Lexicon Pharmaceuticals Gross Profit yearly trend continues to be fairly stable with very little volatility. Gross Profit is likely to outpace its year average in 2022. During the period from 2010 to 2022, Lexicon Pharmaceuticals Gross Profit regression line of anual values had slope of 5,781,638 and arithmetic mean of  56,242,526. Lexicon Pharmaceuticals Direct Expenses is fairly stable at the moment as compared to the past year. Lexicon Pharmaceuticals reported Direct Expenses of 1.74 Million in 2021. Cost of Revenue is likely to rise to about 2.5 M in 2022, whereas Consolidated Income is likely to drop (94.7 M) in 2022.
  
Check Lexicon Pharmaceuticals financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Lexicon main balance sheet or income statement drivers, such as Direct Expenses of 1.9 M, Cost of Revenue of 2.5 M or Gross Profit of 305.8 K, as well as many exotic indicators such as Interest Coverage of 7.93, Long Term Debt to Equity of 1.94 or PPandE Turnover of 0.41. Lexicon financial statements analysis is a perfect complement when working with Lexicon Pharmaceuticals Valuation or Volatility modules. It can also supplement Lexicon Pharmaceuticals' financial leverage analysis and stock options assessment as well as various Lexicon Pharmaceuticals Technical models . Additionally, see the analysis of Lexicon Pharmaceuticals Correlation against competitors.

Lexicon Gross Profit Breakdown

Showing smoothed Gross Profit of Lexicon Pharmaceuticals with missing and latest data points interpolated. Gross profit is a required income statement account that reflects total revenue of Lexicon Pharmaceuticals minus its cost of goods sold. It is profit before Lexicon Pharmaceuticals operating expenses, interest payments and taxes. Gross profit is also known as gross margin. Aggregate revenue Revenues less cost of revenue [CoR] directly attributable to the revenue generation activity.Lexicon Pharmaceuticals' Gross Profit historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Lexicon Pharmaceuticals' overall financial position and show how it may be relating to other accounts over time.
ViewLast Reported (54.75 M)10 Years Trend
Increasing
Stable
   Gross Profit   
Share
       Timeline  

Lexicon Gross Profit Regression Statistics

Arithmetic Mean 56,242,526
Geometric Mean 9,708,862
Coefficient Of Variation 159.44
Mean Deviation 61,139,595
Median 22,066,000
Standard Deviation 89,672,909
Range 318,544,000
R-Value 0.25
R-Squared 0.06
Significance 0.41
Slope 5,781,638

Lexicon Gross Profit History

20121.1 M
20132.2 M
201422.9 M
2015130 M
201679.3 M
201789.8 M
201860.7 M
2019318.8 M
202022.1 M
2021298 K
2022305.8 K

About Lexicon Pharmaceuticals Financial Statements

There are typically three primary documents that fall into the category of financial statements. These documents include Lexicon Pharmaceuticals income statement, its balance sheet, and the statement of cash flows. Lexicon Pharmaceuticals investors use historical funamental indicators, such as Lexicon Pharmaceuticals's Gross Profit, to determine how well the company is positioned to perform in the future. Although Lexicon Pharmaceuticals investors may use each financial statement separately, they are all related. The changes in Lexicon Pharmaceuticals's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on Lexicon Pharmaceuticals's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet, but not equivalent to net income shown on the income statement. We offer a historical overview of the basic patterns found on Lexicon Pharmaceuticals Financial Statements. Understanding these patterns can help to make the right decision on long term investment in Lexicon Pharmaceuticals. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for 2022
Gross Profit298 K305.8 K

Be your own money manager

Our tools can tell you how much better you can do entering a position in Lexicon Pharmaceuticals without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.

Did you try this?

Run Companies Directory Now

   

Companies Directory

Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals
All  Next Launch Module

Becoming a Better Investor with Macroaxis

Macroaxis puts the power of mathematics on your side. We analyze your portfolios and positions such as Lexicon Pharmaceuticals using complex mathematical models and algorithms, but make them easy to understand. There is no real person involved in your portfolio analysis. We perform a number of calculations to compute absolute and relative portfolio volatility, correlation between your assets, value at risk, expected return as well as over 100 different fundamental and technical indicators.

Build Optimal Portfolios

Align your risk with return expectations

Fix your portfolio
By capturing your risk tolerance and investment horizon Macroaxis technology of instant portfolio optimization will compute exactly how much risk is acceptable for your desired return expectations
Additionally, see the analysis of Lexicon Pharmaceuticals Correlation against competitors. You can also try Portfolio Anywhere module to track or share privately all of your investments from the convenience of any device.

Complementary Tools for analysis

When running Lexicon Pharmaceuticals price analysis, check to measure Lexicon Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Lexicon Pharmaceuticals is operating at the current time. Most of Lexicon Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Lexicon Pharmaceuticals' future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Lexicon Pharmaceuticals' price. Additionally, you may evaluate how the addition of Lexicon Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.
Portfolio Suggestion
Get suggestions outside of your existing asset allocation including your own model portfolios
Go
Idea Optimizer
Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio
Go
Focused Opportunities
Build portfolios using our predefined set of ideas and optimize them against your investing preferences
Go
Probability Of Bankruptcy
Get analysis of equity chance of financial distress in the next 2 years
Go
Content Syndication
Quickly integrate customizable finance content to your own investment portal
Go
Stock Screener
Find equities using custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook.
Go
Portfolio Diagnostics
Use generated alerts and portfolio events aggregator to diagnose current holdings
Go
Commodity Channel Index
Use Commodity Channel Index to analyze current equity momentum
Go
Price Exposure Probability
Analyze equity upside and downside potential for a given time horizon across multiple markets
Go
Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals
Go
Portfolio Anywhere
Track or share privately all of your investments from the convenience of any device
Go
Is Lexicon Pharmaceuticals' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Lexicon Pharmaceuticals. If investors know Lexicon will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Lexicon Pharmaceuticals listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth YOY
(0.63) 
Market Capitalization
426.5 M
Quarterly Revenue Growth YOY
0.7
Return On Assets
(0.33) 
Return On Equity
(0.69) 
The market value of Lexicon Pharmaceuticals is measured differently than its book value, which is the value of Lexicon that is recorded on the company's balance sheet. Investors also form their own opinion of Lexicon Pharmaceuticals' value that differs from its market value or its book value, called intrinsic value, which is Lexicon Pharmaceuticals' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Lexicon Pharmaceuticals' market value can be influenced by many factors that don't directly affect Lexicon Pharmaceuticals' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Lexicon Pharmaceuticals' value and its price as these two are different measures arrived at by different means. Investors typically determine Lexicon Pharmaceuticals value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Lexicon Pharmaceuticals' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.